Wednesday, March 1
PLA Annual General Meeting
At its first Annual General Meeting, PLA endorsed its 3-year strategic plan to implement a Digital Trust Ecosystem (DTE) in healthcare. PLA members also confirmed the appointment of eight Directors representing the diversity of its membership.
Tuesday, April 25
PLA Speaker: VP of Quality, Trust & Safety James Gannon
Event Agenda: Computer Software Assurance (CSA), Blockchain Validation, Lab Equipment Qualification, Cell & Gene Therapy, as well as understanding and applying the recently published ‘ISPE GAMP 5 A Risk-Based Approach to Compliant GxP Computerized Systems: Second Edition’.
Tuesday, April 25 – Thursday, April 27
LogiPharma Europe 2023
PLA Executive Director Daniel Fritz will present the Debrief Round Table “Implementing Blockchain at Scale: How to leverage distributed ledger technology to deliver a step-change in commercial scale traceability.”
Wednesday, May 3 – Thursday, May 4
IFPW: International Federation of Pharma Wholesalers
PLA Presence: Executive Director Daniel Fritz and Board Chair Brian Thornley
IFPW’s annual CEO Roundtable assembles chief executives of wholesaler and national distribution association members of the International Federation of Pharmaceutical Wholesalers (IFPW) to discuss the opportunities and challenges facing the global pharmaceutical industry and distribution sector.
Monday, May 8 – Tuesday, May 9
2023 ISPE Europe Annual Conference
PLA Presence: Executive Director Daniel Fritz
This European Annual Conference draws pharmaceutical and biopharmaceutical professionals at all levels of the industry – from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment and services, and global regulatory agencies.
Wednesday, May 24 – Thursday, May 25
Manufacturing Chemist LIVE
PLA Presence: Vice President, Quality, Trust & Safety James Gannon
A two-day conference and exhibition that addresses key drivers in the drug manufacturing sector, such as automation, digitalization, sustainability and compliance, and provides the insights that forward-thinking companies need to ready themselves for the pharmaceutical industry of tomorrow.